Saturday July 4 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Cangene Corporation

Cangene is a world leader in the development , manufacture, and commercialization of specialty hyperimmune plasma and biotechnology products. Cangene has built two decades of success with the life-antibody products, such as WinRho®SDF. We are the leader in the fight against infectious diseases such as smallpox, hepatitis B, and anthrax.


Contact Details:
155 innovation Drive
Winnipeg
Manitoba
R3T 5Y3
Canada
Tel:(204) 275-4178
Fax:(204) 269-7003
Email:sales@cangene.com
WWW:

www.cangene.com/




Loading...

Recent Publications by Cangene Corporation:

Pathogen safety of intravenous Rh immunoglobulin liquid and other immune globulin products: enhanced nanofiltration and manufacturing process overview.
Plasma products for therapeutic use pose specific challenges in...
5th November, 2008
Product Development, Cangene Corporation, Winnipeg, Manitoba, Canada. Am J Ther. 2008 Sep-Oct;15(5):435-43.
DOI Direct Link
Comparative pharmacokinetics of liquid and lyophilized formulations of IV RhIG immune globulin.
To compare the pharmacokinetics, safety, and tolerability of the liquid...
15th October, 2008
Cangene Corporation, Medical Affairs, 155 Innovation Drive, Winnipeg, Biologicals. 2008 Jul;36(4):256-62. Epub 2008 Apr 10.
DOI Direct Link
Preparation and characterization of monopegylated human granulocyte-macrophage colony-stimulating factor.
ABSTRACT Conjugates of recombinant human granulocyte-macrophage...
15th April, 2008
Cangene Corporation, Mississauga, ON, Canada M9W 6A9. J Interferon Cytokine Res. 2008 Feb;28(2):101-12.
DOI Direct Link
Evaluating Burkholderia pseudomallei Bip proteins as vaccines and Bip antibodies as detection agents.
Burkholderia pseudomallei is a biothreat agent and an important natural...
4th April, 2008
Cangene Corporation, Mississauga, ON, Canada. FEMS Immunol Med Microbiol. 2008 Jan;52(1):78-87. Epub 2007 Nov 11.
DOI Direct Link
On the influence of vector design on antibody phage display.
Phage display technology is an established technology particularly useful...
23rd March, 2007
Cangene Corporation, 3403 American Drive, Mississauga, Ontario L4V 1T4, J Biotechnol. 2007 Jan 20;127(4):626-37. Epub 2006 Sep 22.
DOI Direct Link

View more Cangene Corporation research publications.

Press Releases on Cangene Corporation:

BioPortfolio Logo
Alliance for Biosecurity Testifies Before Congress on Funding for Medical Countermeasure Development 18th March, 2009 Alliance for Biosecurity

WASHINGTON, March 18 /PRNewswire-USNewswire/ -- David P. Wright, Co-Chair of the Alliance for Biosecurity and Chairman and CEO of PharmAthene, Inc., testified today before the House Labor, Health

BioNews Results for Cangene Corporation:

Upfront Chromatography Licenses Use of EBA Technology to Cangene Corporation (CC:CNJ)
BioSpace:  Jun 18 2009 6:14AM Matching: cangene
Cangene to host third quarter fiscal 2009 conference call on Friday June 12, 2009 at 11:00 a.m. Eastern
TickerTech.com:  Jun 11 2009 4:11AM Matching: cangene
Cangene to host third quarter fiscal 2009 conference call on Friday June 12, 2009 at 11:00 a.m. Eastern
Pharma Live:  Jun 11 2009 8:08PM Matching: cangene
Cangene's HepaGam B receives approval in Israel
PharmaBiz:  Jun 10 2009 1:29PM Matching: cangene
Cangene Corporation (CC:CNJ) Receives First Overseas Approval for HepaGam B(R)
BioSpace:  Jun 5 2009 2:38PM Matching: cangene
Promote your company here: BioNewsCast - Press Release Distribution

View more Cangene Corporation news.

Cangene Corporation Patents:

US Patent No.Title
6271344 Enhanced affinity hyaluronan binding peptides
5200327 Expression system for the secretion of bioactive human granulocyte macrophage colony stimulating factor (GM-CSF) and other heterologous proteins from streptomyces
5409818 Nucleic acid amplification process
5514590 Expression system comprising DNA encoding the signal peptide of protease B from Streptomyces griseus
5616485 Streptomyces proteases and improved streptomyces strains for expression of peptides and polypeptides

View more Cangene Corporation patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 592 times since April 2007, the link to the organisation's website has been followed 74 times

Recent Search Terms used to find this page: Cangene Corporation | Cangene Corporation | cangene | cangene | CANGENE CORP | cangene corporation | cangene pharmaceutical | Cangene in | cangene | 155 Innovation, Winnipeg, Manitoba | .

Search for more companies in Winnipeg

Search for more companies in Manitoba



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Cangene Corporation

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.